3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other hematologic neoplasm
1
Lymphoid
1
Conditions
Motor Activity
4
Colorectal Neoplasms
3
Lymphoma
2
Colonic Neoplasms
2
Weight Loss
1
Waldenstrom Macroglobulinemia
1
Urinary Bladder Neoplasms
1
Triple Negative Breast Neoplasms
1
Recurrence
1
Rectal Neoplasms
1
Polycystic Ovary Syndrome
1
Obesity
1
Neoplasms
1
Multiple Endocrine Neoplasia Type 1
1
Medical Oncology
1
Malnutrition
1
Lymphoma, T-Cell, Cutaneous
1
Lymphoma, Follicular
1
Lymphoma, B-Cell, Marginal Zone
1
Leukemia, Lymphocytic, Chronic, B-Cell
1
Leukemia, B-Cell
1
Glioma
1
Glioblastoma
1
Fasting
1
Esophageal Neoplasms
1
Endometrial Neoplasms
1
Colorectal Cancer Prevention
1
Carcinoma, Non-Small-Cell Lung
1
Carcinoma, Intraductal, Noninfiltrating
1
Breast Neoplasms
1
Interventions
Cyclophosphamide
8
ibrutinib
5
fludarabine phosphate
5
fludarabine
5
pirtobrutinib
4
Mesna
4
obinutuzumab
3
acalabrutinib
3
Mycophenolic Acid
3
Melphalan
3
venetoclax
2
Whole-Body Irradiation
2
Tacrolimus
2
Rituximab
2
Peripheral Blood Stem Cell Transplantation
2
Patient Reported Outcome Measures
2
Busulfan
2
Bone Marrow Transplantation
2
ARQ531
2
ricolinostat
1
idelalisib
1
idecabtagene vicleucel
1
Vincristine
1
Stem Cell Transplantation
1
Rabeprazole
1
Prednisone
1
Leukapheresis
1
Itraconazole
1
Filgrastim
1
Doxorubicin
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Leukemia, B-Cell
×
Diet
×
1 year
×
Clear all
NCT07487428
2026-03-23
CLL-IMPACT
Technical University of Munich
Phase NA
Recruiting
50 enrolled